Innovation Endeavors

Innovation Endeavors is a Palo Alto–based venture capital firm founded in 2010 that backs early-stage technology companies in the United States and Israel. With offices in Silicon Valley, New York and Tel Aviv, it invests across sectors including artificial intelligence software, fintech, cybersecurity, robotics, climate tech, computing infrastructure, life sciences, logistics, and the physical economy. The firm supports founders developing transformative technologies at the intersection of data, computation and engineering, aiming to accelerate growth and global impact. Its portfolio reflects a focus on innovative solutions addressing emerging global needs.

Dror Berman

Managing Partner

Avi Bharadwaj

Principal

Scott Brady

Managing Partner

Joel Dudley

Partner

Dhruv Iyer

Investor

Past deals in Chicago, IL

Exicure

Venture Round in 2017
Exicure, founded in 2011 and headquartered in Chicago, Illinois, is a clinical-stage biotechnology company specializing in the development of therapeutics using its proprietary spherical nucleic acid (SNA) technology. Its pipeline includes AST-008 for advanced solid tumors, XCUR-FXN for Friedreich’s ataxia, and XCUR17 targeting interleukin 17 receptor alpha. Exicure has collaborations with Allergan Pharmaceuticals International Limited and DERMELIX, LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.